XML 103 R87.htm IDEA: XBRL DOCUMENT v3.20.4
Selected Quarterly Financial Data (Unaudited) (Narrative) (Details) - USD ($)
$ / shares in Units, $ in Thousands, shares in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Quarterly Financial Information Disclosure [Abstract]                      
Revenues $ 252,828 $ 237,835 $ 157,785 $ 214,010 $ 264,865 $ 233,590 $ 238,263 $ 218,378 $ 862,459 $ 955,097 $ 859,634
Gross Profit 135,514 133,698 71,929 119,159 141,975 130,111 131,190 121,438 460,300 524,715 469,110
Net income 24,140 6,850 (27,400) 5,927 14,933 6,970 5,695 1,021 9,517 28,620 40,854
Acquisition and integration costs 600 800 1,100 1,600 1,900 1,700 $ 3,000 7,900     1,100
Restructuring And Related Costs $ 1,600 1,000 3,200                
Manufacturing consolidation costs   $ 600 1,600 $ 1,800 $ 1,400 $ 1,400          
Other expense               $ 3,900 355 5,188 0
Plant underutilization cost     6,600                
Impairment charges                 $ 0 $ 312 $ 4,212
Product rationalization costs     $ 4,300                
Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 0.2 0.2     0.6            
EPS:                      
Basic (in dollars per share) $ 0.84 $ 0.24 $ (0.96) $ 0.21 $ 0.53 $ 0.25 $ 0.20 $ 0.04 $ 0.33 $ 1.01 $ 1.45
Diluted (in dollars per share) $ 0.81 $ 0.23 $ (0.96) $ 0.20 $ 0.49 $ 0.23 $ 0.19 $ 0.04 $ 0.32 $ 0.97 $ 1.41